| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 165.72M | 146.72M | 144.38M | 152.04M | 147.63M | 157.45M |
| Gross Profit | 41.66M | 39.66M | 39.44M | 39.04M | 41.13M | 46.35M |
| EBITDA | 13.98M | 9.98M | 9.26M | 7.18M | 11.05M | 19.61M |
| Net Income | 4.07M | 832.00K | 651.00K | -644.00K | 3.72M | 12.64M |
Balance Sheet | ||||||
| Total Assets | 96.07M | 81.37M | 75.20M | 84.61M | 94.27M | 67.74M |
| Cash, Cash Equivalents and Short-Term Investments | 4.04M | 5.58M | 4.70M | 4.46M | 3.90M | 6.20M |
| Total Debt | 26.95M | 19.81M | 21.39M | 27.60M | 37.68M | 12.89M |
| Total Liabilities | 54.73M | 42.07M | 36.83M | 47.38M | 56.23M | 33.42M |
| Stockholders Equity | 41.34M | 39.30M | 38.37M | 37.23M | 38.04M | 34.31M |
Cash Flow | ||||||
| Free Cash Flow | 4.10M | 4.23M | 10.72M | 13.39M | -16.82M | 10.54M |
| Operating Cash Flow | 4.45M | 8.26M | 14.62M | 19.71M | -7.59M | 14.89M |
| Investing Cash Flow | -4.08M | -3.92M | -3.86M | -6.70M | -16.50M | -4.54M |
| Financing Cash Flow | -2.89M | -3.47M | -10.51M | -12.41M | 21.81M | -11.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.23B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
70 Outperform | £50.34M | 7.74 | 10.10% | ― | 15.50% | 314.96% | |
67 Neutral | £282.81M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
63 Neutral | £487.82M | 11.70 | 7.52% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £597.48M | 1.55 | -35.25% | ― | -20.36% | 44.33% | |
53 Neutral | £50.38M | -28.65 | -10.09% | 2.09% | -5.97% | 14.75% |